• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实验动物视网膜下注射技术方法及应用的进展

Advances in technical methods and applications of subretinal injections in experimental animals.

作者信息

Song Chunyan, Ji Yuke, Wang Yun, Yang Weihua

机构信息

Shenzhen Eye Hospital, Shenzhen Eye Medical Center, Southern Medical University, Shenzhen, China.

出版信息

Front Vet Sci. 2025 Apr 30;12:1574519. doi: 10.3389/fvets.2025.1574519. eCollection 2025.

DOI:10.3389/fvets.2025.1574519
PMID:40370828
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12075335/
Abstract

The subretinal injection technique is an important intraocular drug delivery modality that allows access to the subretinal space to directly act on target cells or the administration of medications, markedly improving the therapeutic efficacy of ocular diseases. Subretinal injection in experimental animals is a commonly used manipulation method for investigating vitreoretinal diseases, particularly when gene therapy and cell therapy studies are involved. In this study, we conducted a systematic review on the injection methods, operation sites, post-injection indicators, as well as the progress and significance of subretinal injection in experimental animals, discussed and compared the advantages and disadvantages of the subretinal injection technique, summarized its specific application of subretinal injection in experimental animals, and explored the development and application of this new technology of subretinal injection, hoping to offer insights that may facilitate the further development of this technology.

摘要

视网膜下注射技术是一种重要的眼内给药方式,它能够进入视网膜下间隙,直接作用于靶细胞或给药,显著提高眼部疾病的治疗效果。在实验动物中进行视网膜下注射是研究玻璃体视网膜疾病常用的操作方法,尤其是在涉及基因治疗和细胞治疗研究时。在本研究中,我们对实验动物视网膜下注射的方法、操作部位、注射后指标以及进展和意义进行了系统综述,讨论并比较了视网膜下注射技术的优缺点,总结了其在实验动物中的具体应用,并探讨了视网膜下注射这项新技术的发展与应用,希望能提供有助于该技术进一步发展的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb84/12075335/c5b195564419/fvets-12-1574519-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb84/12075335/336cca1d83ac/fvets-12-1574519-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb84/12075335/19745d007117/fvets-12-1574519-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb84/12075335/c5b195564419/fvets-12-1574519-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb84/12075335/336cca1d83ac/fvets-12-1574519-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb84/12075335/19745d007117/fvets-12-1574519-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb84/12075335/c5b195564419/fvets-12-1574519-g003.jpg

相似文献

1
Advances in technical methods and applications of subretinal injections in experimental animals.实验动物视网膜下注射技术方法及应用的进展
Front Vet Sci. 2025 Apr 30;12:1574519. doi: 10.3389/fvets.2025.1574519. eCollection 2025.
2
Subretinal Injection: A Review on the Novel Route of Therapeutic Delivery for Vitreoretinal Diseases.视网膜下注射:玻璃体视网膜疾病治疗性给药新途径综述
Ophthalmic Res. 2017;58(4):217-226. doi: 10.1159/000479157. Epub 2017 Sep 1.
3
How Advanced are Nanocarriers for Effective Subretinal Injection?用于有效视网膜下注射的纳米载体有多先进?
Int J Nanomedicine. 2024 Sep 10;19:9273-9289. doi: 10.2147/IJN.S479327. eCollection 2024.
4
Subretinal Injection Techniques for Retinal Disease: A Review.视网膜疾病的视网膜下注射技术:综述
J Clin Med. 2022 Aug 12;11(16):4717. doi: 10.3390/jcm11164717.
5
Biomechanical considerations for optimising subretinal injections.优化视网膜下注射的生物力学考虑因素。
Surv Ophthalmol. 2024 Sep-Oct;69(5):722-732. doi: 10.1016/j.survophthal.2024.05.004. Epub 2024 May 24.
6
Feasibility of Direct Vitrectomy-Sparing Subretinal Injection for Gene Delivery in Large Animals.直接玻璃体切除术保留的视网膜下注射在大型动物中基因传递的可行性。
Curr Eye Res. 2024 Aug;49(8):879-887. doi: 10.1080/02713683.2024.2343335. Epub 2024 Apr 26.
7
The Role of Subretinal Injection in Ophthalmic Surgery: Therapeutic Agent Delivery and Other Indications.视网膜下注射在眼科手术中的作用:治疗剂输送和其他适应证。
Int J Mol Sci. 2023 Jun 23;24(13):10535. doi: 10.3390/ijms241310535.
8
Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study.经视网膜下腔递送达 RGX-314 治疗新生血管性年龄相关性黄斑变性的基因治疗:1/2a 期剂量递增研究。
Lancet. 2024 Apr 20;403(10436):1563-1573. doi: 10.1016/S0140-6736(24)00310-6. Epub 2024 Mar 27.
9
Intraoperative Visualization of Subretinal Injection and Retinal Detachment in Rats.大鼠视网膜下注射及视网膜脱离的术中可视化
J Vis Exp. 2025 Mar 7(217). doi: 10.3791/67483.
10
Effect of subretinal injection on retinal structure and function in a rat oxygen-induced retinopathy model.视网膜下注射对大鼠氧诱导视网膜病变模型视网膜结构和功能的影响。
Mol Vis. 2017 Nov 29;23:832-843. eCollection 2017.

本文引用的文献

1
Biomechanical considerations for optimising subretinal injections.优化视网膜下注射的生物力学考虑因素。
Surv Ophthalmol. 2024 Sep-Oct;69(5):722-732. doi: 10.1016/j.survophthal.2024.05.004. Epub 2024 May 24.
2
Techniques for subretinal injections in animals.动物视网膜下注射技术。
Vet Ophthalmol. 2025 Mar;28(2):506-518. doi: 10.1111/vop.13219. Epub 2024 May 3.
3
Feasibility of Direct Vitrectomy-Sparing Subretinal Injection for Gene Delivery in Large Animals.直接玻璃体切除术保留的视网膜下注射在大型动物中基因传递的可行性。
Curr Eye Res. 2024 Aug;49(8):879-887. doi: 10.1080/02713683.2024.2343335. Epub 2024 Apr 26.
4
Subretinal AAV delivery of RNAi-therapeutics targeting reduces choroidal neovascularization in a large animal model.在大型动物模型中,通过视网膜下注射腺相关病毒(AAV)递送靶向RNA干扰疗法可减少脉络膜新生血管形成。
Mol Ther Methods Clin Dev. 2024 Mar 22;32(2):101242. doi: 10.1016/j.omtm.2024.101242. eCollection 2024 Jun 13.
5
Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study.经视网膜下腔递送达 RGX-314 治疗新生血管性年龄相关性黄斑变性的基因治疗:1/2a 期剂量递增研究。
Lancet. 2024 Apr 20;403(10436):1563-1573. doi: 10.1016/S0140-6736(24)00310-6. Epub 2024 Mar 27.
6
CRISPR/SaCas9-based gene editing rescues photoreceptor degeneration throughout a rhodopsin-associated autosomal dominant retinitis pigmentosa mouse model.基于 CRISPR/SaCas9 的基因编辑挽救了整个视紫红质相关常染色体显性遗传性视网膜色素变性小鼠模型中的光感受器变性。
Exp Biol Med (Maywood). 2023 Oct;248(20):1818-1828. doi: 10.1177/15353702231199069. Epub 2023 Oct 14.
7
GMP-grade human neural progenitors delivered subretinally protect vision in rat model of retinal degeneration and survive in minipigs.经视网膜下腔递送符合 GMP 标准的人神经前体细胞可保护视网膜变性大鼠模型的视力,并在小型猪体内存活。
J Transl Med. 2023 Sep 25;21(1):650. doi: 10.1186/s12967-023-04501-z.
8
Soluble CX3CL1-expressing retinal pigment epithelium cells protect rod photoreceptors in a mouse model of retinitis pigmentosa.可溶性 CX3CL1 表达的视网膜色素上皮细胞在视网膜色素变性的小鼠模型中保护杆状光感受器。
Stem Cell Res Ther. 2023 Aug 21;14(1):212. doi: 10.1186/s13287-023-03434-0.
9
Gene augmentation therapy to rescue degenerative photoreceptors in a Cwc27 mutant mouse model.基因增强疗法挽救 Cwc27 突变小鼠模型中变性的光感受器
Exp Eye Res. 2023 Sep;234:109596. doi: 10.1016/j.exer.2023.109596. Epub 2023 Jul 20.
10
The Role of Subretinal Injection in Ophthalmic Surgery: Therapeutic Agent Delivery and Other Indications.视网膜下注射在眼科手术中的作用:治疗剂输送和其他适应证。
Int J Mol Sci. 2023 Jun 23;24(13):10535. doi: 10.3390/ijms241310535.